Analysed JADE BIOSCIENCES INC (JBIO:NASDAQ) News Sources
Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody
26-05-2026
yahoo.com
Assessing Jade Biosciences (JBIO) Valuation After Recent Share Price Weakness And Longer Term Gains
29-05-2026
yahoo.com
Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy
29-05-2026
yahoo.com
Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy
01-06-2026
yahoo.com
Jade Biosciences’ JADE101 Delivers Deep IgA Cuts, Clearing Path for Kidney Trials
02-06-2026
marketbeat.com
Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
05-06-2026
yahoo.com
Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
26-06-2026
yahoo.com
What is the current price of JADE BIOSCIENCES INC (JBIO:NASDAQ)?
The current price of JADE BIOSCIENCES INC (JBIO:NASDAQ) is $20.86.
JADE BIOSCIENCES INC (JBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of JADE BIOSCIENCES INC (JBIO:NASDAQ) since the previous trading day is $0.38.
JADE BIOSCIENCES INC (JBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of JADE BIOSCIENCES INC (JBIO:NASDAQ) since the previous trading day is 1.8555%.
What is the most recent average sentiment score for JADE BIOSCIENCES INC (JBIO:NASDAQ)?
The most recent average sentiment score for JADE BIOSCIENCES INC (JBIO:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for JADE BIOSCIENCES INC (JBIO:NASDAQ)?
The most recent sentiment for JADE BIOSCIENCES INC (JBIO:NASDAQ) is .
SEC-8K** Filing Available For JADE BIOSCIENCES INC (JBIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.